Protalix BioTherapeutics, Inc. (PLX) › Net IncomeProtalix BioTherapeutics, Inc. (PLX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$31.44M2010: -$29.00M2011: -$36.53M2012: -$11.62M2013: -$27.79M2014: -$29.94M2015: $58.04M2016: -$29.36M2017: -$83.44M2018: -$26.46M2019: -$18.28M2020: -$6.52M2021: -$27.58M2022: -$14.93M2023: $8.31M2024: $2.93M2025: -$6.60M-$6.60M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$6.60M-325.2%2024$2.93M-64.7%2023$8.31M+155.7%2022-$14.93M+45.9%2021-$27.58M-322.8%2020-$6.52M+64.3%2019-$18.28M+30.9%2018-$26.46M+68.3%2017-$83.44M-184.1%2016-$29.36M-150.6%2015$58.04M+293.8%2014-$29.94M-7.7%2013-$27.79M-139.2%2012-$11.62M+68.2%2011-$36.53M-26.0%2010-$29.00M+7.8%2009-$31.44M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share